Marine Streptomyces are prolific producers of majority of bioactive secondary metabolites which are used in pharmaceutical industry as effective drugs against life threatening diseases. The cytotoxic activity of the pure compound 1, 2-benzene dicarboxylic acid, mono 2-ethylhexyl ester (DMEHE) from marine derived actinomycete Streptomyces sp. VITSJK8 was investigated against mouse embryonic fibroblast (NIH 3T3) and human keratinocyte (HaCaT) normal cell lines, human hepatocellular liver carcinoma (HepG 2) and human breast adenocarcinoma (MCF-7) cell lines by using MTT assay. The compound DMEHE exhibited IC 50 values of 42, 100, 250 and 500 µg/ ml against HepG2, MCF-7, HaCaT and NIH 3T3 cell lines, respectively. The effect of DMEHE on the growth of cancer cell lines was expressed as the % of viability. Cell viability was recorded as 67.7%, 78.14%, 82.23% and 96. 11% in HepG2, MCF-7, HaCaT and NIH 3T3 cells, respectively. The results of the study conclude that the bioactive compound isolated from the potential isolate Streptomyces sp. VITSJK8 exhibited cytotoxic activity against HepG2 and MCF-7 cancer cell lines and low toxicity against normal HaCaT and NIH 3T3 cell lines.
arine microorganisms continue to be a potential source of bioactive secondary metabolites. 70% of earth surface is covered with water and it has been estimated that only 1% of microorganisms has been cultured and identified (1) . Marine actinomyetes are ubiquitous in marine sediments but at lower numbers than in soil (2) . Cancer is one of the major causes of death in developed countries, together with cardiac and cerebrovascular diseases (11 
16S rRNA secondary structure and restriction sites analysis
The secondary structure and the restriction sites in the 16S rRNA sequence of the isolate VITSJK8 were predicted using online softwares
Genebee and NEB Cutter (version 2.0) respectively.
Extraction, purification and identification of bioactive compound
The seed was prepared by inoculation of one mature colony of Streptomyces sp. VITSJK8 in 50 ml of ISP1 medium and kept in a shaker at 120 rpm for 3 days. Furthermore, the seeds were inoculated in 1l of ISP1 medium and kept in a shaker at 120 rpm for 9 days. After the fermentation period, the culture was harvested and the secondary metabolites were extracted using ethyl acetate (EA)
as solvent (1: 
Spectroscopic analysis of the purified compound
The UV-visible absorption spectra of the compound were determined using UV-visible spectrometer (SL, 210, ELICO, India) and λ max was measured. The key functional groups present in the compound were determined by Fourier transform infrared spectroscopy (FTIR) (Thermo Nicolet-330 USA). Gas chromatography-mass spectroscopy (GC-MS) was used by injecting (1 µl) of the sample with the injection temperature at 220 °C into the spectrometer equipped with HP-5 capillary column. Proton (1H) and carbon (13C) 1 H and 13 C nuclear magnetic resonance spectra (NMR) (Bruker Advance III 500 mHz A V 500) was used to exploit the atomic structure of the compound (16) . The structure of the compound was established with the help of spectral data obtained from various spectroscopic techniques. The 3D structure of the compound was obtained by using
ChemDraw software (Ultra 8.0).
Analysis of cytotoxic activity of 1, 2-Benzene dicarboxylic acid, mono (2-ethylhexyl) ester
The compound DMEHE isolated from 
Structural elucidation of the compound
Based on the spectral data, the structure of the 
